# Post Market Study Using the Xoft Axxent System

> **NCT01017549** · NA · COMPLETED · sponsor: **Xoft, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Electronic brachytherapy (Axxent System)

## Key facts

- **NCT ID:** NCT01017549
- **Lead sponsor:** Xoft, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-26
- **Primary completion:** 2013-06-06
- **Final completion:** 2016-05-07
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017549, "Post Market Study Using the Xoft Axxent System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01017549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*